Publication:
Disability and cost for diabetic patients at a public district hospital in Thailand

dc.contributor.authorArthorn Riewpaiboonen_US
dc.contributor.authorSusmita Chatterjeeen_US
dc.contributor.authorWachara Riewpaiboonen_US
dc.contributor.authorPiyanuch Piyauthakiten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherCenter for Disease Dynamics, Economics and Policyen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherWaritchaphum Hospitalen_US
dc.contributor.otherPHFIen_US
dc.date.accessioned2018-05-03T08:13:52Z
dc.date.available2018-05-03T08:13:52Z
dc.date.issued2011-04-01en_US
dc.description.abstractObjective The study determined the rate of disability among diabetic patients at a public district hospital in Thailand and compared the costs of illness among different levels of severity of disability. This was the first such study carried out in Thailand. Methods The study was conducted at Waritchaphum Hospital in northeastern Thailand. Data were collected from 475 randomly selected diabetic patients identified by the World Health Organization's International Classification of Diseases, tenth revision (ICD-10 codes E10 - E14) who received treatment from the study hospital during the fiscal year of 2008. The disability levels were determined by using Thailand ministerial guidelines as well as the Barthel index score. Cost-of-illness estimates followed the prevalence-based approach and it presented the societal perspective of cost-of-illness of diabetes in 2008. Key findings The study results showed that 9.68% of the study participants had physical impairment while 9.26% had impairment in eyesight. The Barthel index score showed that 13.5% of the study participants were disabled. When comparing costs between independent and disabled persons, considering the Barthel index score, average costs for the disabled diabetic persons were significantly higher than for those who were independent (US$2700.29 versus 598.24; P < 0.001). Conclusions The study concluded that the presence of complications and disability among diabetic patients impacts severely on Thai society. At present, the Thai government allocates US$187.5 per annum to registered disabled persons as a disability living allowance. The study found a large difference between the direct economic outlay of the patients and the allowance provided, which suggests that there is probably a need to revise the welfare payment upwards. © 2011 Royal Pharmaceutical Society.en_US
dc.identifier.citationInternational Journal of Pharmacy Practice. Vol.19, No.2 (2011), 84-93en_US
dc.identifier.doi10.1111/j.2042-7174.2010.00078.xen_US
dc.identifier.issn09617671en_US
dc.identifier.other2-s2.0-79952607792en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/11950
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79952607792&origin=inwarden_US
dc.subjectHealth Professionsen_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleDisability and cost for diabetic patients at a public district hospital in Thailanden_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79952607792&origin=inwarden_US

Files

Collections